Free Trial

Immunocore (IMCR) SEC Filings & 10K Form

Immunocore logo
$32.42 -0.14 (-0.43%)
(As of 11/20/2024 ET)

Recent Immunocore SEC Filings

DateFilerForm TypeView
11/14/2024
5:40 AM
Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/08/2024
3:20 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM
Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
6:22 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
6:00 AM
Immunocore (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/16/2024
5:46 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
12:49 PM
Immunocore (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SC 13G
08/29/2024
6:21 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:21 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:06 AM
Immunocore (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/30/2024
4:22 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
3:43 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2024
3:46 PM
Immunocore (Issuer)
KRISHANA RANJEEV (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2024
3:17 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:15 PM
Bell John Irving (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Herbst Roy Steven (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Immunocore (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:50 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:13 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:00 AM
Immunocore (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
3:34 PM
Immunocore (Filer)
Form ARS
04/05/2024
3:35 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:34 PM
Immunocore (Filer)
Form 424B7
04/02/2024
3:45 PM
Immunocore (Filer)
Form PRE 14A
04/01/2024
11:36 AM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
7:51 PM
Immunocore (Filer)
Form S-3ASR
03/20/2024
7:55 PM
Immunocore (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Immunocore (Subject)
Form SC 13G
03/07/2024
8:45 PM
GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
Form SC 13D/A
02/28/2024
3:15 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:19 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:33 AM
Immunocore (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
5:46 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
3:15 PM
Immunocore (Issuer)
Jallal Bahija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
GOLL JOHN (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
Di Donato Brian (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:16 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:57 AM
Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/06/2024
10:00 AM
Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

02/01/2024
4:25 PM
BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
Form SC 13D/A
01/05/2024
3:17 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
6:19 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:55 PM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
3:51 PM
Immunocore (Issuer)
Jallal Bahija (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:52 PM
Immunocore (Issuer)
Kaul Siddharth (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:53 PM
Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:54 PM
Immunocore (Issuer)
Peterson Kristine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:55 PM
Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:57 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:41 PM
Di Donato Brian (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:42 PM
Bell John Irving (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:43 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:45 PM
Coy Travis Alan (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:47 PM
GOLL JOHN (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
5:25 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
4:30 PM
Immunocore (Subject)
Jallal Bahija (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
12:54 PM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/30/2023
7:33 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMCR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners